Clinical Trial Update: A Study of Fezolinetant to Treat Hot Flashes in Women Going Through Menopause [Phase 3]

View source ↗

Summary

A Phase 3 trial of fezolinetant for vasomotor symptoms in menopausal women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause
• Vasomotor Symptoms

Drugs mentioned

• Fezolinetant (fezolinetant)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Vasomotor Symptoms | Phase 3 | Status: COMPLETED